Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer.

Our study provides a nanovesicle-based delivery platform to promote the efficacy of chemotherapeutic drugs with fewer side effects. This novel strategy may ameliorate the present obstacles to the clinical treatment of lung cancer.